ReWalk Robotics (LFWD) to Release Earnings on Wednesday
ReWalk Robotics (NASDAQ:LFWD – Get Free Report) will issue its quarterly earnings data before the market opens on Wednesday, May 15th. Analysts expect the company to announce earnings of ($0.70) per share for the quarter. ReWalk Robotics has set its FY 2024 guidance at EPS and its Q1 2024 guidance at EPS.Parties interested in registering for the company’s conference call can do so using this link.
ReWalk Robotics (NASDAQ:LFWD – Get Free Report) last announced its earnings results on Tuesday, February 27th. The company reported ($0.35) EPS for the quarter, topping the consensus estimate of ($0.91) by $0.56. The business had revenue of $6.88 million during the quarter, compared to the consensus estimate of $7.20 million. ReWalk Robotics had a negative net margin of 159.76% and a negative return on equity of 28.19%. On average, analysts expect ReWalk Robotics to post $-2 EPS for the current fiscal year and $-1 EPS for the next fiscal year.
ReWalk Robotics Stock Performance
Shares of NASDAQ LFWD opened at $5.04 on Monday. ReWalk Robotics has a 1-year low of $3.90 and a 1-year high of $9.10. The company has a market capitalization of $42.84 million, a price-to-earnings ratio of -1.76 and a beta of 2.06. The business’s 50 day moving average price is $5.06.
Wall Street Analyst Weigh In
Separately, HC Wainwright reaffirmed a “buy” rating and set a $9.00 price target on shares of ReWalk Robotics in a research report on Monday, April 15th.
Check Out Our Latest Research Report on ReWalk Robotics
About ReWalk Robotics
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.
Featured Articles
Receive News & Ratings for ReWalk Robotics Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for ReWalk Robotics and related companies with MarketBeat.com’s FREE daily email newsletter.
